• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为疫苗接种动态中的一个控制参数,加强免疫计划的延迟。

Delay in booster schedule as a control parameter in vaccination dynamics.

作者信息

Wang Zhen, Röst Gergely, Moghadas Seyed M

机构信息

Agent-Based Modelling Laboratory, York University, Toronto, M3J 1P3, Canada.

Mathematical Institute, University of Oxford, Woodstock Road, Oxford, OX2 6GG, UK.

出版信息

J Math Biol. 2019 Dec;79(6-7):2157-2182. doi: 10.1007/s00285-019-01424-6. Epub 2019 Sep 7.

DOI:10.1007/s00285-019-01424-6
PMID:31494722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6858909/
Abstract

The use of multiple vaccine doses has proven to be essential in providing high levels of protection against a number of vaccine-preventable diseases at the individual level. However, the effectiveness of vaccination at the population level depends on several key factors, including the dose-dependent protection efficacy of vaccine, coverage of primary and booster doses, and in particular, the timing of a booster dose. For vaccines that provide transient protection, the optimal scheduling of a booster dose remains an important component of immunization programs and could significantly affect the long-term disease dynamics. In this study, we developed a vaccination model as a system of delay differential equations to investigate the effect of booster schedule using a control parameter represented by a fixed time-delay. By exploring the stability analysis of the model based on its reproduction number, we show the disease persistence in scenarios where the booster dose is sub-optimally scheduled. The findings indicate that, depending on the protection efficacy of primary vaccine series and the coverage of booster vaccination, the time-delay in a booster schedule can be a determining factor in disease persistence or elimination. We present model results with simulations for a vaccine-preventable bacterial disease, Heamophilus influenzae serotype b, using parameter estimates from the previous literature. Our study highlights the importance of timelines for multiple-dose vaccination in order to enhance the population-wide benefits of herd immunity.

摘要

事实证明,使用多剂疫苗对于在个体层面提供针对多种疫苗可预防疾病的高水平保护至关重要。然而,疫苗接种在人群层面的有效性取决于几个关键因素,包括疫苗的剂量依赖性保护效力、初免和加强剂量的覆盖率,尤其是加强剂量的接种时间。对于提供短暂保护的疫苗,加强剂量的最佳接种计划仍然是免疫规划的重要组成部分,并且可能会显著影响疾病的长期动态。在本研究中,我们开发了一个疫苗接种模型,作为一个延迟微分方程组,以使用由固定时间延迟表示的控制参数来研究加强接种计划的效果。通过基于其繁殖数对模型进行稳定性分析,我们展示了在加强剂量接种计划欠佳的情况下疾病的持续存在情况。研究结果表明,根据初免疫苗系列的保护效力和加强疫苗接种的覆盖率,加强接种计划中的时间延迟可能是疾病持续存在或消除的决定性因素。我们使用先前文献中的参数估计值,通过模拟给出了针对一种疫苗可预防细菌性疾病——b型流感嗜血杆菌的模型结果。我们的研究强调了多剂疫苗接种时间安排对于增强群体层面的 herd immunity 益处的重要性。 (注:“herd immunity”直译为“群体免疫”,但在医学领域可能有更专业准确的表述,这里保留英文未翻译,需结合具体专业知识进一步确定准确译法)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/ab1689d479f8/285_2019_1424_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/ee57fb17c9a7/285_2019_1424_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/0edebca7f3d8/285_2019_1424_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/480693460d04/285_2019_1424_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/77cda4611740/285_2019_1424_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/f1afa4ab356c/285_2019_1424_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/ab1689d479f8/285_2019_1424_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/ee57fb17c9a7/285_2019_1424_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/0edebca7f3d8/285_2019_1424_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/480693460d04/285_2019_1424_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/77cda4611740/285_2019_1424_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/f1afa4ab356c/285_2019_1424_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f0/6858909/ab1689d479f8/285_2019_1424_Fig6_HTML.jpg

相似文献

1
Delay in booster schedule as a control parameter in vaccination dynamics.作为疫苗接种动态中的一个控制参数,加强免疫计划的延迟。
J Math Biol. 2019 Dec;79(6-7):2157-2182. doi: 10.1007/s00285-019-01424-6. Epub 2019 Sep 7.
2
Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b.模拟加强剂量疫苗接种计划的效果及对公共卫生免疫计划的建议:以b型流感嗜血杆菌为例
BMC Public Health. 2017 Sep 13;17(1):705. doi: 10.1186/s12889-017-4714-9.
3
Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.未接种加强针的b型流感嗜血杆菌结合疫苗初次免疫后的疫苗接种失败情况。
Lancet. 1997 Apr 26;349(9060):1197-202. doi: 10.1016/s0140-6736(96)06392-1.
4
Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population immunity in Kilifi, Kenya: a 15-year regional surveillance study.无加强剂量 b 型流感嗜血杆菌疫苗接种对肯尼亚基利菲侵袭性 b 型流感嗜血杆菌病、鼻咽携带和人群免疫的影响:一项长达 15 年的区域性监测研究。
Lancet Glob Health. 2016 Mar;4(3):e185-94. doi: 10.1016/S2214-109X(15)00316-2. Epub 2016 Feb 5.
5
Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.英国b型流感嗜血杆菌结合疫苗接种后的抗体浓度与临床保护作用
JAMA. 2000 Nov 8;284(18):2334-40. doi: 10.1001/jama.284.18.2334.
6
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.3批b型流感嗜血杆菌结合疫苗的批间一致性、安全性及免疫原性:一项针对婴儿的III期随机多中心研究结果
Vaccine. 2017 Jun 16;35(28):3564-3574. doi: 10.1016/j.vaccine.2017.05.018. Epub 2017 May 20.
7
Modelling the impact of vaccination on curtailing Haemophilus influenzae serotype 'a'.模拟疫苗接种对控制A型流感嗜血杆菌的影响。
J Theor Biol. 2015 Dec 21;387:101-10. doi: 10.1016/j.jtbi.2015.09.026. Epub 2015 Oct 8.
8
Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.婴幼儿期接种乙型流感嗜血杆菌结合疫苗后的长期免疫持久性和 B 细胞记忆及加强免疫反应
Clin Infect Dis. 2014 Apr;58(7):949-59. doi: 10.1093/cid/ciu001. Epub 2014 Jan 7.
9
Changes in measurement of Haemophilus influenzae serotype b (Hib) vaccination coverage --- National Immunization Survey, United States, 2009.2009 年美国全国免疫调查中 Hib 疫苗接种覆盖率测量值的变化。
MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1069-72.
10
Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.菲律宾儿童中使用白喉-破伤风-全细胞百日咳-乙型肝炎-低抗原含量b型流感嗜血杆菌联合疫苗进行三剂基础免疫和加强免疫的免疫原性、反应原性及安全性
Hum Vaccin. 2010 Aug;6(8):664-72. doi: 10.4161/hv.6.8.12155.

引用本文的文献

1
Delays in the vaccination of infants between 2 and 18 months of age: associated factors in Chile.婴儿在 2 至 18 个月之间推迟接种疫苗:智利的相关因素。
BMC Public Health. 2023 Sep 28;23(1):1882. doi: 10.1186/s12889-023-16769-3.
2
Safety and Immunogenicity of a Heterologous Booster of Protein Subunit Vaccine MVC-COV1901 after Two Doses of Adenoviral Vector Vaccine AZD1222.两剂腺病毒载体疫苗AZD1222后蛋白亚单位疫苗MVC-COV1901异源加强针的安全性和免疫原性。
Vaccines (Basel). 2022 Oct 11;10(10):1701. doi: 10.3390/vaccines10101701.
3
Opinion Polls and Antibody Response Dynamics of Vaccination with COVID-19 Booster Vaccines.

本文引用的文献

1
Cost-effectiveness of a potential vaccine candidate for Haemophilus influenzae serotype 'a'.用于预防流感嗜血杆菌 a 型的潜在疫苗候选物的成本效益分析。
Vaccine. 2018 Mar 14;36(12):1681-1688. doi: 10.1016/j.vaccine.2018.01.047. Epub 2018 Feb 16.
2
Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b.模拟加强剂量疫苗接种计划的效果及对公共卫生免疫计划的建议:以b型流感嗜血杆菌为例
BMC Public Health. 2017 Sep 13;17(1):705. doi: 10.1186/s12889-017-4714-9.
3
Dynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population.
新冠病毒加强疫苗接种的民意调查及抗体反应动态
Vaccines (Basel). 2022 Apr 20;10(5):647. doi: 10.3390/vaccines10050647.
4
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?初次免疫和加强免疫之间的间隔长短:是否会影响疫苗免疫原性?
Vaccines (Basel). 2021 Mar 20;9(3):289. doi: 10.3390/vaccines9030289.
5
Nonlinear model predictive control with logic constraints for COVID-19 management.用于新冠疫情管理的具有逻辑约束的非线性模型预测控制
Nonlinear Dyn. 2020;102(4):1965-1986. doi: 10.1007/s11071-020-05980-1. Epub 2020 Dec 2.
加拿大原住民群体中针对a型流感嗜血杆菌荚膜多糖的自然获得性抗体动态变化
Prev Med Rep. 2016 Jan 26;3:145-50. doi: 10.1016/j.pmedr.2016.01.004. eCollection 2016 Jun.
4
Modelling the impact of vaccination on curtailing Haemophilus influenzae serotype 'a'.模拟疫苗接种对控制A型流感嗜血杆菌的影响。
J Theor Biol. 2015 Dec 21;387:101-10. doi: 10.1016/j.jtbi.2015.09.026. Epub 2015 Oct 8.
5
Seven challenges in modeling vaccine preventable diseases.疫苗可预防疾病建模中的七个挑战。
Epidemics. 2015 Mar;10:11-5. doi: 10.1016/j.epidem.2014.08.004. Epub 2014 Aug 27.
6
Combating pertussis resurgence: One booster vaccination schedule does not fit all.应对百日咳疫情反弹:一种加强疫苗接种方案并不适用于所有人。
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):E472-7. doi: 10.1073/pnas.1415573112. Epub 2015 Jan 20.
7
Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP).流感嗜血杆菌 b 型疾病的预防和控制:免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2014 Feb 28;63(RR-01):1-14.
8
Comparing Haemophilus influenzae type b conjugate vaccine schedules: a systematic review and meta-analysis of vaccine trials.比较 b 型流感嗜血杆菌结合疫苗方案:疫苗试验的系统评价和荟萃分析。
Pediatr Infect Dis J. 2013 Nov;32(11):1245-56. doi: 10.1097/INF.0b013e31829f0a7e.
9
Can vaccine legacy explain the British pertussis resurgence?疫苗接种史能否解释英国百日咳卷土重来?
Vaccine. 2013 Dec 2;31(49):5903-8. doi: 10.1016/j.vaccine.2013.09.020. Epub 2013 Oct 16.
10
Effectiveness of Haemophilus influenzae type b vaccines administered according to various schedules: systematic review and meta-analysis of observational data.不同免疫程序接种乙型流感嗜血杆菌疫苗的效果:观察性数据的系统评价和荟萃分析。
Pediatr Infect Dis J. 2013 Nov;32(11):1261-9. doi: 10.1097/INF.0b013e3182a14e57.